Russia to release COVID-19 vaccine trial data by Monday

Russia will soon release data on pre-clinical and clinical studies of the new coronavirus vaccine that was approved earlier this week. "Data on preclinical and clinical studies will be published in the coming days, possibly by Monday," said news agency TASS reported, citing health minister Mikhail Murashko.

Russian President Vladimir Putin said on Tuesday that Russia had become the first country to grant regulatory approval to a COVID-19 vaccine after less than two months of human testing, a move Moscow likened to its success in the Cold War-era space race.

Russia's decision to grant approval to the vaccine has however raised concerns among some experts. The vaccine, which will be called "Sputnik V" in homage to the world's first satellite launched by the Soviet Union, has however not yet completed its final trials.

Countering the analysis, the wellbeing



pastor said it was to a great extent because of the reality "that more information must be gotten on research," including that not every person realizes that "the antibody depends on a stage, on which six items have just been made." 

Russian specialists state that the primary clump of its Covid-19 immunization would be prepared for specialists inside about fourteen days.

Meanwhile, Vietnam has registered to buy a Russian COVID-19 vaccine, state television reported today as it fights a new outbreak after going several months with no local cases.

The Russian business conglomerate Sistema has said it expects to put the vaccine, developed by Moscow's Gamaleya Institute, into mass production by the end of the year.

Kirill Dmitriev, head of Russia's sovereign wealth fund, said Russia had already received foreign requests for 1 billion doses.